Skip to main content

5 articles related to "Cytochrome P450 2c19"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 19 Feb 2019

Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications

in Neuropharmacology

Marin Veldic
Ahmed T. Ahmed
Caren J. Blacker
Jennifer R. Geske
Joanna M. Biernacka
Kristin L. Borreggine
Katherine M. Moore
Miguel L. Prieto
Jennifer L. Vande Voort
Paul E. Croarkin

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00083

9,597 views
16 citations

Systematic Review

Published on 15 Oct 2021

Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis

in Gastrointestinal and Hepatic Pharmacology

Yuko Morino
Mitsushige Sugimoto
Naoyoshi Nagata
Ryota Niikiura
Eri Iwata
Mariko Hamada
Yusuke Kawai
Tatsuhiro Fujimiya
Hironori Takeuchi
Sakae Unezaki

Frontiers in Pharmacology

doi 10.3389/fphar.2021.759249

7,460 views
25 citations

Original Research

Published on 24 Nov 2016

Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention

in Pharmacogenetics and Pharmacogenomics

Hong Sun
Qiang Qu
Zhen-Fan Chen
Sheng-Lan Tan
Hai-Jun Zhou
Jian Qu
Hui Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2016.00453

5,784 views
19 citations

Original Research

Published on 24 Aug 2022

Platelet reactivity after clopidogrel loading in patients with acute ischemic stroke

in Stroke

Yukiko Enomoto
Kenji Shoda
Daisuke Mizutani
Hirofumi Matsubara
Yusuke Egashira
Toru Iwama

Frontiers in Neurology

doi 10.3389/fneur.2022.887243

4,015 views
1 citation

Original Research

Published on 22 Jan 2026

CYP2C19 intermediate and poor metabolizer statuses may be associated with coronary atherosclerosis among patients with type 2 diabetes mellitus

in Precision Medicine

Nan Cai
Youqian Li
Jingfeng Liu
Changjing Huang
Haifeng Hong
Hanlin Li
Junyin Peng

Frontiers in Medicine

doi 10.3389/fmed.2026.1738919

569 views